Intraci sterna Ily administered cholecystokinin produced long lasting hypothermia in mice, and the hypothermic effect
.
In this paper, we are demonstrating that the hypothermic action of CCK8 can be antagonized by benzodiazepines and Ro 15 1788 i n mice.
Male ddY strain mice weighing 20 to 24 g were kept in cages and allowed free access to food and drinking water. Experiments were carried out in the laboratory at a controlled temperature of 24±1 °C and relative humidity of 55±5% with lighting from 06:00 to 18:00. The body temperature of mice was measured at a period from 10:00 to 12:00. Each mouse was kept in a wire-mesh cage individually. The rectal temperature of mice was measured by means of an electric thermometer by inserting the thermistor stick into the rectum at a depth of about 20 mm and leaving it for at least 10 sec in the rectum. Aqueous 0.4% brilliant blue solution was used as a vehicle for the intracisternal injection of CCK8. Brilliant blue was used for confirming whether the proper intracis ternal injection was made or not. Each mouse was killed after the experiment, and the spread of brilliant blue in the brain was observed. Ten ul of CCK8 solution which contained 200 ng of CCK8 dissolved in the vehicle was injected into the cerebellomedul lary cistern by using a J-shaped stainless needle according to the method devised by Ueda et al. (14) An intracisternal administration of 200 ng of CCK8 to mice produced an initial pronounced decrease followed by a long lasting decrease of the rectal temperature.
The maximum effects of CCK8 on the rectal temperature appeared about 10 min after the CCK8 injection, and the decrease in the temperature was 2 to 3°C (Fig. 1) . Intraperitoneal adminis tration of CDP (5 mg/kg) and intracisternal injection of 0.4% brilliant blue solution caused an initial rapid decrease followed by a long lasting decrease of the rectal temper ature of mice. However, the hypothermic effect of CCK8 in mice was significantly inhibited by 5 In the previous paper (5), it was demon strated that an intracisternal administration of 1 i g of CCK8 to mice produced anti nociceptive effects which were significantly antagonized by naloxone hydrochloride (5 mg/kg), benzodiazepines such as CDP (2 mg/kg), DZP (1 mg/kg) and FZP (1 mg/ kg) and Ro 15-1788 (0.5 mg/kg), all of which were administered intraperitoneally. However, 5 mg/kg of naloxone hydro chloride failed to antagonize the hypothermic effects of CCK8, indicating that the hypo thermic action of CCK8 seems not to be mediated by endogenous opioid peptides. On the other hand, all of the benzodiazepines and a benzodiazepine antagonist, Ro 15 1788, used in the present experiments sig nificantly inhibited the hypothermic effect of CCK8 and the order of the activity of the benzodiazepines and Ro 15-1788 on the antagonism against CCK8 action to induce hypothermia and antinociception are quite similar to each other. The thermoregulating center in the hypothalamus is well known to be sensitive to dopamine antagonists such as chlorpromazine.
Benzodiazepines, however, have no antidopamine action, being indicative that CCK8 hypothermia may not be mediated by dopaminergic neurons as was suggested by Zetler (8).
We found that 10-6 to 10-5 M of CDP and DZP competitively antagonized the CCK8 action of contracting the isolated guinea-pig gallbladder muscle (12, 13) . On the other hand, the intraperitoneal doses of the benzodiazepines required for reversing CCK8 hypothermia and antinociception (5) were as low as 0.5 to 2 mg/kg. The concentrations of the benzodiazepines in the brain which were administered at these doses are considered to be much lower than those required for antagonizing the CCK action in the gall bladder. Therefore, details of the mechanism of the antagonism between CCK8 and the benzodiazepines in the central nervous system remain unclear at present. Ro 15 1788 has been claimed (15) to be an an tagonist of benzodiazepines with regard to their central effects. However, Ro 15-1788 and the benzodiazepines used behaved as if they shared a common mechanism of action with regards to the antagonism of the CCK8 action in the central nervous system. Upon precisely observing the antagonism between CCK8 and CDP and DZP, the body tempera ture of mice which received benzodiazepines along with CCK8 was higher than that of mice which received the benzodiazepine alone. These results are difficult to explain on the basis of the present findings. One possibility is that CCK8 might possess dual actions, one of which is a strong hypothermic action and the other a weak hyperthermic action, and the former action was selectively blocked by the benzodiazepines. Magnani et al. (1984) demonstrated that CCK8 produced dual actions in the release of acetylcholine from the cerebral cortex. Higher doses of CCK8 inhibited the release of acetylcholine, while lower doses of CCK8 stimulated it, and only the stimulating action of CCK8 was antagonized by pro glumide (160 mg/kg), which has been claimed to be a specific antagonist of CCK8 (16) . In our present work, 200 mg/kg of proglumide failed to antagonize the hypo thermic effect of CCK8, despite of its dose being considerably high. We have no conclusive explanation for this phenomenon at present. Further investigations are neces sary before we reach a conclusion.
